Vontobel Holding Ltd. Sells 565 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV)

Vontobel Holding Ltd. trimmed its holdings in shares of Shockwave Medical, Inc. (NASDAQ:SWAV) by 16.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,923 shares of the company’s stock after selling 565 shares during the quarter. Vontobel Holding Ltd.’s holdings in Shockwave Medical were worth $557,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of SWAV. Covestor Ltd increased its holdings in Shockwave Medical by 484.9% in the 3rd quarter. Covestor Ltd now owns 427 shares of the company’s stock valued at $85,000 after buying an additional 354 shares during the period. International Assets Investment Management LLC increased its holdings in Shockwave Medical by 18,122.1% in the 4th quarter. International Assets Investment Management LLC now owns 141,586 shares of the company’s stock valued at $26,981,000 after buying an additional 140,809 shares during the period. American Century Companies Inc. increased its holdings in Shockwave Medical by 109.0% in the 3rd quarter. American Century Companies Inc. now owns 170,866 shares of the company’s stock valued at $34,019,000 after buying an additional 89,094 shares during the period. AMI Asset Management Corp bought a new stake in shares of Shockwave Medical during the 4th quarter valued at approximately $4,092,000. Finally, Wellington Management Group LLP grew its holdings in shares of Shockwave Medical by 33.5% during the 3rd quarter. Wellington Management Group LLP now owns 1,805,771 shares of the company’s stock valued at $359,529,000 after purchasing an additional 453,048 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

SWAV has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $335.00 target price (up from $270.00) on shares of Shockwave Medical in a report on Monday, April 8th. Needham & Company LLC reaffirmed a “hold” rating on shares of Shockwave Medical in a research note on Friday, April 5th. Leerink Partnrs lowered shares of Shockwave Medical from an “outperform” rating to a “market perform” rating in a research note on Friday, April 5th. CL King reissued a “neutral” rating on shares of Shockwave Medical in a research note on Monday, April 8th. Finally, Morgan Stanley reissued an “equal weight” rating and set a $335.00 target price (up from $285.00) on shares of Shockwave Medical in a research note on Monday, April 8th. Ten equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $309.11.

Shockwave Medical Price Performance

Shares of NASDAQ:SWAV opened at $328.60 on Tuesday. The company has a quick ratio of 10.73, a current ratio of 11.76 and a debt-to-equity ratio of 1.09. The firm has a market capitalization of $12.29 billion, a PE ratio of 84.91, a P/E/G ratio of 2.44 and a beta of 0.92. Shockwave Medical, Inc. has a twelve month low of $157.00 and a twelve month high of $331.58. The company has a 50-day moving average price of $287.78 and a two-hundred day moving average price of $230.12.

Shockwave Medical (NASDAQ:SWAV) last issued its earnings results on Thursday, February 15th. The company reported $1.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.92 by $0.24. The firm had revenue of $202.98 million during the quarter, compared to analyst estimates of $199.43 million. Shockwave Medical had a net margin of 20.17% and a return on equity of 23.97%. The company’s quarterly revenue was up 41.0% on a year-over-year basis. During the same quarter last year, the business earned $3.71 earnings per share. Equities analysts forecast that Shockwave Medical, Inc. will post 4.94 EPS for the current year.

Insiders Place Their Bets

In other news, insider Isaac Zacharias sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $224.69, for a total value of $898,760.00. Following the completion of the transaction, the insider now directly owns 63,920 shares in the company, valued at $14,362,184.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Isaac Zacharias sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $224.69, for a total value of $898,760.00. Following the completion of the transaction, the insider now directly owns 63,920 shares in the company, valued at $14,362,184.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Trinh Phung sold 1,287 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $232.18, for a total transaction of $298,815.66. Following the completion of the transaction, the vice president now owns 32,933 shares of the company’s stock, valued at $7,646,383.94. The disclosure for this sale can be found here. Insiders sold 93,813 shares of company stock worth $23,762,679 over the last quarter. 3.40% of the stock is currently owned by company insiders.

Shockwave Medical Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.